Literature DB >> 3413497

Autologous red cell agglutination assay for HIV-1 antibodies: simplified test with whole blood.

B E Kemp1, D B Rylatt, P G Bundesen, R R Doherty, D A McPhee, D Stapleton, L E Cottis, K Wilson, M A John, J M Khan.   

Abstract

An antibody detection procedure based on agglutination of autologous red cells has been developed for samples of whole blood. A nonagglutinating monoclonal antibody to human red blood cells conjugated to a synthetic peptide antigen (in this case residues 579 to 601 of the HIV-1 envelope precursor, Arg-Ile-Leu-Ala-Val-Glu-Arg-Tyr-Leu-Lys-Asp-Gln-Gln-Leu-Leu-Gly-Ile-Trp- Gly-Cys - Ser-Gly-Lys) permitted the detection of antibodies to the human immunodeficiency virus type 1 (HIV-1) in 10 microliters of whole blood within 2 minutes. Agglutination was specifically inhibited by addition of synthetic peptide antigen but not by unrelated peptides. The frequency of false positive results was 0.1% with HIV-1 seronegative blood donors (n = 874). The false negative results were approximately 1% (n = 81). The autologous red cell agglutination test is potentially suitable for simple, rapid, qualitative screening for antibodies to a variety of antigens of medical and veterinary diagnostic significance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413497     DOI: 10.1126/science.3413497

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  13 in total

1.  Detection of antibodies to human immunodeficiency virus type 1 in whole blood and saliva by using a passive hemagglutination test.

Authors:  M B Vasudevachari; K Uffelman; P F Pierce; H C Lane; N P Salzman
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

Review 2.  Laboratory tests for detection of human immunodeficiency virus type 1 infection.

Authors:  N F Nuwayhid
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

3.  Evaluation of a 2-minute anti-human immunodeficiency virus (HIV) test using the autologous erythrocyte agglutination technique with populations differing in HIV prevalence.

Authors:  S Sirivichayakul; P Phanuphak; S Tanprasert; S Thanomchat; C Uneklabh; T Phutiprawan; C Mungklavirat; Y Panjurai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

4.  Computer predictions of antigenic domains in human immunodeficiency virus-1 envelope glycoprotein: comparison with reported experimental data.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1990-04       Impact factor: 2.332

5.  Synthetic peptides representing sequences within gp41 of HIV as immunogens for murine T- and B-cell responses.

Authors:  L E Brown; D O White; C Agius; B E Kemp; N Yatzakis; P Poumbourios; D A McPhee; D C Jackson
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

6.  Whole-blood agglutination assay for on-site detection of human immunodeficiency virus infection.

Authors:  Amita Gupta; Vijay K Chaudhary
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

7.  Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.

Authors:  S J Bell; D A Cooper; B E Kemp; R R Doherty; R Penny
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

8.  Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI).

Authors:  S J Bell; D A Cooper; B E Kemp; R R Doherty; R Penny
Journal:  Clin Exp Immunol       Date:  1992-10       Impact factor: 4.330

9.  A rapid, point-of-care red blood cell agglutination assay detecting antibodies against SARS-CoV-2.

Authors:  Robert L Kruse; Yuting Huang; Heather Smetana; Eric A Gehrie; Timothy K Amukele; Aaron A R Tobian; Heba H Mostafa; Zack Z Wang
Journal:  Biochem Biophys Res Commun       Date:  2021-03-15       Impact factor: 3.575

Review 10.  Approaches for the development of rapid serological assays for surveillance and diagnosis of infections caused by zoonotic flaviviruses of the Japanese encephalitis virus serocomplex.

Authors:  Jody Hobson-Peters
Journal:  J Biomed Biotechnol       Date:  2012-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.